Attitudes about COVID-19 Testing among Black Adults in the United States
- PMID: 34720555
- PMCID: PMC8545482
- DOI: 10.18865/ed.31.4.519
Attitudes about COVID-19 Testing among Black Adults in the United States
Abstract
Purpose: Black Americans are disproportionately affected by coronavirus disease 2019 (COVID-19) hospitalizations and deaths. Decreasing health disparities requires widespread uptake of COVID-19 testing, but attitudes about COVID-19 testing among Black Americans have not been studied. We aimed to characterize knowledge, attitudes, and beliefs about COVID-19 testing among Black parents.
Methods: Semi-structured interviews were conducted and analyzed using a phenomenology approach with 26 self-identified Black parents after telemedicine visits with a children's health center. Interviews were recorded and transcribed; 65% were double coded with a resultant free-marginal interrater kappa score of 86.8%.
Results: Most participants were women, spent time inside the homes of friends or family members, and almost half knew someone diagnosed with COVID-19. Three central themes emerged regarding COVID-19 testing decision making, including: 1) perceived COVID-19 disease susceptibility; 2) barriers to testing, with subthemes including trust in test accuracy and safety, perceived stigma of a positive test result, and impact of racism on self-efficacy; and 3) cues to action.
Conclusions: When considering these themes as constructs of the Health Belief Model, we are better able to understand Black Americans' views of COVID-19 testing and motivations for accessing testing. Culturally responsive educational campaigns delivered by trusted community members should aim to improve understanding about disease transmission and types of tests available. Importantly, framing testing as a means to ensure safety may improve self-efficacy to obtain testing. Lastly, the health community should learn from these conversations with Black Americans so that disease prevention and mitigation strategies prioritize health equity.
Keywords: COVID-19; Diagnostic Techniques and Procedures; Health Care Disparities; SARS-CoV-2; Testing.
Copyright © 2021, Ethnicity & Disease, Inc.
Conflict of interest statement
Competing Interests: Dr. Schaffer DeRoo serves as a consultant for the Pfizer Pediatric Pneumococcal PEGASUS (Pneumococcal Expert Group of Advisors for Scientific Understanding and Insight) – US project. The remaining authors have no conflicts to disclose.
References
-
- APM Research Lab . The color of coronavirus: COVID-19 deaths by race and ethnicity in the U.S. American Public Media. March 5, 2021. Last accessed June 25, 2021 from https://www.apmresearchlab.org/covid/deaths-by-race.
-
- Centers for Disease Control and Prevention . COVID data tracker: United States COVID-19 cases, deaths, and laboratory testing (NAATs) by state, territory, and jurisdiction. August 8, 2021. Last accessed August 9, 2021 from https://covid.cdc.gov/covid-data-tracker/#cases_totaldeaths.
-
- Centers for Disease Control and Prevention . Risk for COVID-19 infection, hospitalization, and death by race/ethnicity. July 16, 2021. Last accessed August 9, 2021 from https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-disc....
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous